Curaleaf Holdings (CURLF) Revenue (2019 - 2026)
Curaleaf Holdings' (CURLF) quarterly Revenue came in at $324.2 million in Q1 2026, up 5.74% year-on-year from $306.6 million in Q1 2025, and little changed quarter-over-quarter from $323.4 million in Q4 2025.
Curaleaf Holdings (CURLF) Revenue (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Revenue history runs 8 years deep, the most recent figure standing at $324.2 million for Q1 2026.
- On a quarterly basis, Revenue rose 5.74% year-over-year to $324.2 million in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 1.51% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 4.96% from the prior year.
- Revenue steadied at $324.2 million in Q1 2026 per CURLF's latest filing, from $323.4 million in the prior quarter.
- Across five years, Revenue topped out at $352.5 million in Q4 2022 and bottomed at $345269.0 in Q4 2023.
- The 5-year median for Revenue is $325.0 million (2022), against an average of $306.9 million.
- Across the five-year window, Revenue tumbled 99.9% in 2023 and surged 93320.2% in 2024, its largest moves.
- Year by year, Revenue stood at $352.5 million in 2022, then tumbled by 99.9% to $345269.0 in 2023, then jumped by 93320.2% to $322.6 million in 2024, then increased by 0.25% to $323.4 million in 2025, then increased by 0.27% to $324.2 million in 2026.
- Per Business Quant, the three latest CURLF Revenue figures stand at $324.2 million (Q1 2026), $323.4 million (Q4 2025), and $320.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Curaleaf Holdings | 7.17 Bn | 7.17 Bn | 157.29 Mn | 324.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 324.23 Mn |
| Dec 31, 2025 | 323.36 Mn |
| Sep 30, 2025 | 320.24 Mn |
| Jun 30, 2025 | 314.52 Mn |
| Mar 31, 2025 | 306.62 Mn |
| Dec 31, 2024 | 322.55 Mn |
| Sep 30, 2024 | 330.53 Mn |
| Jun 30, 2024 | 342.29 Mn |
| Mar 31, 2024 | 338.93 Mn |
| Dec 31, 2023 | 345,269.00 |
| Sep 30, 2023 | 333.17 Mn |
| Jun 30, 2023 | 335.55 Mn |
| Dec 31, 2022 | 352.49 Mn |
| Sep 30, 2022 | 325.81 Mn |
| Jun 30, 2022 | 326.98 Mn |
| Mar 31, 2022 | 313.07 Mn |
| Dec 31, 2021 | 308.68 Mn |
| Sep 30, 2021 | 315.70 Mn |
| Jun 30, 2021 | 312.21 Mn |
| Mar 31, 2021 | 260.32 Mn |